Endoscopic Retrograde Cholangiopancreatography Market Size, Share & Trends Analysis Report By Product (Endoscopes, Endotherapy Devices), By Procedure (Biliary Sphincterotomy, Biliary Stenting), By End Use, By Region, And Segment Forecasts, 2025 - 2030

Market Size & Trends

The global endoscopic retrograde cholangiopancreatography market size was estimated at USD 2.17 billion in 2024 and is projected to grow at a CAGR of 8.26% from 2025 to 2030. The market is gaining popularity due to its reduced risk of complications and faster recovery compared to traditional surgery. The growing incidence of chronic gastrointestinal and biliary conditions, including Crohn's disease, Barrett's esophagus, and liver disorders, is contributing to the growth.

This growth is majorly driven by the rising incidence of pancreatic and biliary diseases, such as gallstones, pancreatitis, and bile duct obstructions, which are fueling the demand for ERCP procedures. As the population ages and lifestyles change, the prevalence of these conditions is expected to increase, driving market growth. For instance, according to the National Health Service (NHS), more than one in ten adults in the UK has gallstones. Moreover, several studies indicated that the incidence rate of gallstones is anticipated to rise rapidly over the forecast period, driving the demand for ERCP procedures.

Furthermore, advances in endoscopic technology have improved the safety and efficacy of ERCP procedures. For instance, in January 2023, Advantech introduced the MIO-5377R single-board computer as a groundbreaking innovation in the field of endoscope technology. This compact and powerful device is designed to address the traditional challenges faced by endoscopes, offering enhanced performance, reliability, and functionality. Moreover, innovations such as high-definition imaging, better maneuverability of endoscopes, and the development of therapeutic accessories have made ERCP a more precise and effective diagnostic and treatment tool. These technological advancements are attracting both healthcare providers and patients to opt for ERCP procedures.

The rise in the adoption of minimally invasive surgical techniques has led to an increased demand for ERCP procedures, which is expected to drive growth in the industry in the upcoming years. For instance, according to the American Cancer Society's annual report published in January 2024, an estimated 41,630 new cases of liver cancer are expected to be diagnosed in the U.S. In addition, as per the same source, liver cancer is more prevalent in countries in sub- Southeast Asia and Saharan Africa compared to the U.S. It is the most common type of cancer in many of these nations, with over 800,000 new cases diagnosed globally each year. Moreover, liver cancer ranks as a leading cause of cancer-related deaths worldwide, claiming more than 700,000 lives annually.

Moreover, the increased awareness about the benefits of early diagnosis and treatment of pancreatic and biliary diseases has led to a higher demand for minimally invasive procedures such as ERCP. For instance, in October 2023, the Biliary Atresia Awareness Committee launched the Biliary Atresia Awareness Campaign under the guidance of the Gauteng Provincial Solid Organ Transplant Division and the University of the Witwatersrand at Charlotte Maxeke Academic Hospital. The campaign was aimed to raise awareness and support for children affected by biliary atresia. This rare and life-threatening liver disease affects infants by obstructing or obliterating bile ducts. The initiative was focused on educating diverse demographics about biliary atresia, offering resources and support to affected families, advancing research for diagnostic tools and treatments, and fostering collaboration with medical entities globally.

Global Endoscopic Retrograde Cholangiopancreatography Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global endoscopic retrograde cholangiopancreatography market report based on product, procedure, end use, and region.

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Endoscopes
• Endotherapy Devices

Sphincterotomes

Lithotripter

Stents

Cannulas

Forceps

Snares

Catheters

Guiding Wires

Balloons

Baskets

• Visualization Systems
• Energy Devices
• Others
• Procedure Outlook (Revenue, USD Million, 2018 - 2030)
• Biliary Sphincterotomy
• Biliary Stenting
• Biliary Dilatation
• Pancreatic Sphincterotomy
• Pancreatic Duct Stenting
• Pancreatic Duct Dilation
• End use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Outpatient Facilities
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

UK

Germany

France

Italy

Spain

Norway

Sweden

Denmark

• Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

• Latin America

Brazil

Argentina

• Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Please note The report will be delivered in 2-3 business days upon order notification.